Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
5.99
+0.89 (17.45%)
At close: Mar 6, 2026, 4:00 PM EST
6.05
+0.06 (0.99%)
After-hours: Mar 6, 2026, 7:57 PM EST
Shattuck Labs Revenue
In the year 2025, Shattuck Labs had annual revenue of $1.00M, down -82.52%.
Revenue (ttm)
$1.00M
Revenue Growth
-82.52%
P/S Ratio
379.05
Revenue / Employee
$22,727
Employees
44
Market Cap
379.05M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Puma Biotechnology | 228.37M |
| XOMA Royalty | 47.11M |
| X4 Pharmaceuticals | 33.98M |
| Foghorn Therapeutics | 24.52M |
| Opus Genetics | 14.63M |
| Avalo Therapeutics | 192.00K |
STTK News
- 2 days ago - Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 10 days ago - Shattuck Labs Announces Participation in Upcoming March Investor Conferences - GlobeNewsWire
- 4 weeks ago - Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium - GlobeNewsWire
- 2 months ago - Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Analyst Upgrade Boosts Shattuck On Confidence In Next-Gen Inflammatory Bowel Disease Therapy - Benzinga
- 3 months ago - Shattuck Labs to Participate in Upcoming December Investor Conferences - GlobeNewsWire
- 4 months ago - Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 5 months ago - Shattuck Labs, Inc. (STTK) Presents at The United European Gastroenterology (UEG) Congress UEG Week 2025 Transcript - Seeking Alpha